← FDA Drug Approvals (Drugs@FDA)

DIHYDROERGOTAMINE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-01-04

Drug application

FDA Application #

ANDA214105

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIHYDROERGOTAMINE MESYLATE

Generic name

Dihydroergotamine Mesylate

Active ingredients

DIHYDROERGOTAMINE MESYLATE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Discontinued

Sponsor

AMNEAL

First approval

2022-01-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown